- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07349134
WELL-MPN: Una aplicación de estilo de vida digital para pacientes con MPN (WELL-MPN)
Ensayo Controlado Aleatorizado Piloto de una Intervención Digital para Promover el Bienestar, el Empoderamiento y el Aprendizaje de Estilos de Vida para Pacientes con Neoplasias Mieloproliferativas (WELL-MPN)
The goal of this clinical trial is to learn whether a digital lifestyle app can help improve diet, physical activity, symptoms, emotional well-being, and quality of life in adults with myeloproliferative neoplasms (MPNs).
The main questions it aims to answer are:
Can people with MPNs use the WELL-MPN app?
Does using the WELL-MPN app improve diet quality and physical activity?
Does the WELL-MPN app improve MPN-related symptoms, anxiety and depression, confidence in managing health, and overall quality of life?
Researchers will compare participants who use the WELL-MPN digital app with participants who receive written educational materials about diet and physical activity for people with cancer to see if the app leads to greater improvements in lifestyle behaviors, symptoms, and well-being.
Participants will:
Be randomly assigned to use the WELL-MPN app or receive written lifestyle education materials
Use the assigned program or materials over the study period
Complete surveys about diet, physical activity, symptoms, mood, confidence in self-care, and quality of life
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Chi-Joan How
- Número de teléfono: 617-732-5190
- Correo electrónico: jhow@bwh.harvard.edu
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- Mass General Brigham
-
Contacto:
- Chi-Joan How
- Número de teléfono: 6177325190
- Correo electrónico: jhow@bwh.harvard.edu
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Diagnosed with a myeloproliferative neoplasm (MPN) by World Health Organization 2016 criteria
- Adult (age >/= 18)
- Able to comprehend and speak English
- Able to provide informed consent
Exclusion Criteria:
- Unable to comprehend and speak English
- Unable to provide informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: WELL-MPN Digital App
WELL-MPN app and usual care |
Patients randomized to the WELL-MPN arm will be given access to the WELL-MPN digital program (app) which provides lifestyle counseling through an iPad. |
|
Sin intervención: Enhanced Usual Care
Usual care and written literature about diet and physical activity guidelines in patients with cancer |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of patients consented and enrolled onto the study, and number of patients who complete at least 2 out of 3 modules in the app.
Periodo de tiempo: 2 years
|
Primary outcome is feasibility, defined as ≥60% enrollment of eligible patients and ≥70% of patients randomized to the intervention group completing at least 2 out of 3 of app modules. |
2 years
|
|
8-Item Client Satisfaction Scores (CSQ-8)
Periodo de tiempo: Enrollment to 16 weeks after enrollment
|
Acceptability of WELL-MPN as measured by CSQ-8 scores of WELL-MPN. The CSQ-8 is a self-report tool designed to measure patient satisfaction with a received intervention. It consists of 8 items rated on a 4-point Likert scale (from "quite dissatisfied" to "very satisfied"), with higher scores indicating greater satisfaction. WELL-MPN is considered acceptable if >80% of participants on the WELL-MPN arm report a CSQ-8 score >20. |
Enrollment to 16 weeks after enrollment
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Healthy Eating Index calculated from the Automated Self-Administered Dietary Assessment Tool
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Diet quality will be compared between control and WELL-MPN patients. The ASA24 is a free 24-hour dietary recall tool developed by the National Cancer Institute. Responses will be used to calculate a Healthy Eating Index (HEI) score, which is a measure of dietary quality that addresses compliance with the 2015 United States Department of Agriculture dietary guidelines (scores range from 0 to 100, with higher scores indicating greater alignment with dietary guidelines). |
Enrollment to 16 weeks after enrollment.
|
|
Mini Eating Assessment Tool (Mini-EAT) score
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Diet quality will be compared between control and WELL-MPN patients. The Mini-EAT is a 9-item validated brief dietary screener designed for greater ease of administration compared to the ASA-24 but has strong correlation with the HEI. Responses generate a score ranging from 0 to 54, with higher scores reflecting greater adherence to healthy dietary patterns aligned with the Dietary Guidelines for Americans. |
Enrollment to 16 weeks after enrollment.
|
|
Godin Leisure Time Exercise Questionnaire
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Physical activity will be compared between control and WELL-MPN patients. The Godin Leisure Time Exercise Questionnaire is a brief, self-reported tool used to assess a person's usual physical activity during their free time.It consists of three questions asking information on the number of times one engages in mild, moderate, and strenuous physical activity of at least 15-minute durations in a typical week. Higher scores indicate greater physical activity, with scores of less than 14 units indicating insufficient / sedentary activity. |
Enrollment to 16 weeks after enrollment.
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy Short Forms
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Self-efficacy will be compared between control and WELL-MPN patients. The PROMIS Self-Efficacy Short Forms include 4-item scales across domains such as managing daily activities, symptoms, medications, emotions, and social interactions. Each item is rated on a 5-point Likert scale, with higher scores indicating greater self-efficacy. |
Enrollment to 16 weeks after enrollment.
|
|
MPN Symptom Assessment Form (SAF) Total Symptom Score (TSS)
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
MPN symptom scores will be compared between control and WELL-MPN patients. The MPN SAF TSS is a 10-item questionnaire assessing the most representative and clinically relevant MPN symptoms (concentration, early satiety, inactivity, night sweats, itching, bone pain, abdominal discomfort, weight loss, fever), and includes a "worst fatigue" question from the Brief Fatigue Inventory. Each subscale ranges from 0 (absent / as good as it can be) to 10 (worst imaginable / as bad as it can be), and scores are computed as the average of the observed items multiplied by 10 to achieve a 0 to 100 scale. |
Enrollment to 16 weeks after enrollment.
|
|
Hospital Anxiety and Depression Scale (HADS-A and HADS-D):
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Psychological distress will be compared between controls and WELL-MPN patients. The 14-item HADS consists of two 7-item subscales assessing anxiety and depression symptoms in the past week. Each subscale ranges from 0 (no distress) to 21 (maximum distress), with higher scores indicating worse distress. Subscale scores > 8 indicate clinically significant distress; scores can be further interpreted as follows: 8-10 indicates mild distress, 11-14 indicates moderate distress, and 15-21 indicates severe distress. |
Enrollment to 16 weeks after enrollment.
|
|
Functional Assessment of Cancer - General (FACT-G)
Periodo de tiempo: Enrollment to 16 weeks after enrollment.
|
Quality of life will be compared between controls and WELL-MPN patients. The FACT-G consists of four subscales assessing well-being across four domains (physical, functional, emotional, and social). Subscale scores include Functional Well-Being (0-28), Social Well-Being (0-28), Emotional Well-Being (0-24), and Functional Well-Being (0-28) with higher scores reflecting better well-being in each domain. |
Enrollment to 16 weeks after enrollment.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chi-Joan How, Massachusetts General Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Neoplasias por sitio
- Neoplasias
- Enfermedades hematológicas
- Trastornos de la coagulación de la sangre
- Enfermedades de la médula ósea
- Trastornos hemorrágicos
- Trastornos de las plaquetas sanguíneas
- Neoplasias de la Médula Ósea
- Neoplasias Hematológicas
- Enfermedades hemic y linfáticas
- Trombocitosis
- Trastornos mieloproliferativos
- Trombocitemia Esencial
- Policitemia vera
- Mielofibrosis primaria
Otros números de identificación del estudio
- 25-805
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .